In the U.S., the PCR test is the gold standard for COVID testing. Common knowledge would have it that the test is more accurate—and therefore more effective at containing the spread of the dease—than the rapid antigen test.
What if that isn’t quite true?
Guest: Michael Mina, assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health
Host: Lizzie O’Leary
Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.
Hosted on Acast. See acast.com/privacy for more information.
